Supernus Pharmaceuticals is based in Rockville, MD. It has raised $50M in total funding. Latest round: IPO.
Supernus Pharmaceuticals funding overview
Supernus Pharmaceuticals is based in Rockville, MD. Supernus Pharmaceuticals has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is an IPO announced in February 2006. The round record for Supernus Pharmaceuticals runs through 2006; nothing later has been disclosed. Investors on record include New Enterprise Associates, Abingworth Management. 2 distinct backers are named across the disclosed rounds.
Supernus Pharmaceuticals at a glance
Total raised
$50M
Latest round
IPO
Latest round date
February 2006
Headquarters
Rockville, MD
Notable investors
New Enterprise Associates, Abingworth Management
Frequently asked about Supernus Pharmaceuticals funding
How much has Supernus Pharmaceuticals raised?
Supernus Pharmaceuticals has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Supernus Pharmaceuticals?
New Enterprise Associates, Abingworth Management are named among the investors backing Supernus Pharmaceuticals.
What was the latest Supernus Pharmaceuticals funding round?
The most recent disclosed round is an IPO, announced in February 2006.
Where is Supernus Pharmaceuticals based?
Supernus Pharmaceuticals is based in Rockville, MD.
When did Supernus Pharmaceuticals last raise?
The last disclosed Supernus Pharmaceuticals round closed in February 2006 at IPO.
Every Supernus Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Rockville at a similar stage.
Companies related to Supernus Pharmaceuticals (29)
